Home/ Stocks/ VTAK

Catheter Precision, Inc.

VTAK XASE

$1.38 +0.67 (+93.67%) ▲ 15-min delayed

Open

$1.21

High

$1.74

Low

$1.20

Volume

163.29M

Market Cap

$2.57M

About Catheter Precision, Inc.

Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 17 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$432.0K	$-1,690,000	$-1.39
FY 2025	$819.0K	$-17,695,000	$-15.90
Q3 2025	$226.0K	$-2,344,000	$-1.70
Q2 2025	$212.0K	$-5,458,000	$-0.38

TickerDaily Coverage

Why Is Catheter Precision (VTAK) Stock Up 72.6% Today?

Penny Stocks Marcus Rivera · 2h ago

Catheter Precision (VTAK) stock exploded 72.6% on Wednesday, July 8, 2026, closing at $1.205 on...

View All Coverage →

Get VTAK Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Catheter Precision, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.